Research group at Yale university developing synthetic complex molecular targets
The Spiegel Lab focuses on developing new synthetic approaches that will facilitate our understanding and treatment of human disease. Ongoing project areas of interest to the group include:
1. The development of synthetic molecules capable of refocusing the human immune system towards diseased or infected tissues.
2. Total syntheses of complex natural products found in humans. Synthetic access to these materials will allow us to elucidate disease pathways, with an eye toward therapeutics development.
Visit website: https://spiegellab.yale.edu/#ResearchGroup
See also: Yale University - Private Ivy League research university in New Haven, Connecticut
Spiegel Lab News
SRF to develop glucosepane-cleaving antibodies with Spiegel Lab
Lifespan.io (LEAF) - 17-Sep-2017
Anti-glucosepane antibodies may offer new therapies for age-related diseasesRead more...